The virus was getting closer and more personal. Even so, despite our public health officials' and infectious disease specialists' numerous pleas for months to wear masks and socially distance ourselves, people ... We are learning the lessons of the
He also serves on the Infectious Disease Board of the American Board of Internal Medicine. ... He is board certified by the American Board of Internal Medicine in internal medicine and infectious disease.
After the infection is detected, effective treatment with antibiotics can prevent progression to late-stage disease, with small associated harms.
This recommendation was published in the Jan. 26 Morbidity and Mortality Weekly Report, and experts in infectious disease expect it to change practice.
The correct answer is B. Oral fluconazole. This item is Question 96 in MKSAP 18's Infectious Disease section. ... Topical agents such as nystatin are less effective than systemic fluconazole for oropharyngeal candidiasis and are especially ineffective
He is board certified by the American Board of Internal Medicine in internal medicine and infectious disease. ... Currently, Dr. Tan is the physician lead of infectious disease at Summa Health Medical Group and associate professor of internal medicine at
Abraham, MD, MPH, MACP, who is an infectious disease subspecialist, chief of medicine at Saint Vincent Hospital, and a professor of medicine at the University of Massachusetts Medical School in Worcester,
June's issue of ACP Hospitalist features articles on ICU glucose control, Internal Medicine 2009 highlights of the hospitalist track, and MKSAP questions on infectious diseases. ... Part B (dermatology, endocrinology and metabolism, general internal
A 65-year-old man is evaluated during a follow-up visit for stage G3b/A3 chronic kidney disease due to diabetic nephropathy. ... The correct answer is B. Increase lisinopril dose. This item is available to MKSAP 17 subscribers as item 90 in the
The sexual component of the disease can add additional uncertainty. Photo by iStock. ... Markowitz and Peter G. Gulick, DO, FACP, an associate professor in hematology/oncology and infectious disease at Michigan State University College of Osteopathic